Literature DB >> 12800477

Diabetic retinopathy.

Susan Lightman1, Hamish M Towler.   

Abstract

Diabetic retinopathy is the principal cause of irreversible blindness in patients of working age in the industrialized world (1,2). For some types of retinopathy (e.g., proliferative disease), effective treatment in the form of laser photocoagulation has been available for more than 20 years, but many patients seek help too late when treatment is no longer effective. Macular edema, which is much more common in patients with type 2 diabetes mellitus, may be the presenting sign and therefore may already be established at diagnosis. If vision is significantly reduced, current treatment options are often ineffective. Screening of diabetic persons for early signs of retinopathy, which are treatable, improves the visual prognosis. Medical factors such as good blood glucose control, management of hypertension, and regulation of blood lipid levels are also considered to be of major importance.

Entities:  

Mesh:

Year:  2003        PMID: 12800477     DOI: 10.1016/s1098-3597(03)90015-9

Source DB:  PubMed          Journal:  Clin Cornerstone        ISSN: 1873-4480


  20 in total

1.  AGEs Promote Oxidative Stress and Induce Apoptosis in Retinal Pigmented Epithelium Cells RAGE-dependently.

Authors:  Xin-Ling Wang; Tao Yu; Qi-Chang Yan; Wei Wang; Nan Meng; Xue-Jiao Li; Ya-Hong Luo
Journal:  J Mol Neurosci       Date:  2015-02-15       Impact factor: 3.444

Review 2.  Emerging Concepts in the Treatment of Diabetic Retinopathy.

Authors:  Michael Patrick Ellis; Daniella Lent-Schochet; Therlinder Lo; Glenn Yiu
Journal:  Curr Diab Rep       Date:  2019-11-20       Impact factor: 4.810

3.  Fenofibric acid prevents retinal pigment epithelium disruption induced by interleukin-1β by suppressing AMP-activated protein kinase (AMPK) activation.

Authors:  M Villarroel; M Garcia-Ramírez; L Corraliza; C Hernández; R Simó
Journal:  Diabetologia       Date:  2011-03-03       Impact factor: 10.122

4.  Placental growth factor-1 and epithelial haemato-retinal barrier breakdown: potential implication in the pathogenesis of diabetic retinopathy.

Authors:  N Miyamoto; Y de Kozak; J C Jeanny; A Glotin; F Mascarelli; P Massin; D BenEzra; F Behar-Cohen
Journal:  Diabetologia       Date:  2006-12-23       Impact factor: 10.122

5.  Fenofibric acid reduces fibronectin and collagen type IV overexpression in human retinal pigment epithelial cells grown in conditions mimicking the diabetic milieu: functional implications in retinal permeability.

Authors:  Kyle Trudeau; Sumon Roy; Wen Guo; Cristina Hernández; Marta Villarroel; Rafael Simó; Sayon Roy
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-08-11       Impact factor: 4.799

6.  Association of monocyte chemoattractant protein-1 (MCP-1)2518A/G polymorphism with proliferative diabetic retinopathy in northern Chinese type 2 diabetes.

Authors:  Li Dong; Xiao Ying Lv; Bin Jie Wang; Ye Qing Wang; Hua Mu; Zhuo Lei Feng; Ping Liu
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-05-09       Impact factor: 3.117

Review 7.  Advances in the medical treatment of diabetic retinopathy.

Authors:  Rafael Simó; Cristina Hernández
Journal:  Diabetes Care       Date:  2009-08       Impact factor: 17.152

Review 8.  The retinal pigment epithelium: something more than a constituent of the blood-retinal barrier--implications for the pathogenesis of diabetic retinopathy.

Authors:  Rafael Simó; Marta Villarroel; Lídia Corraliza; Cristina Hernández; Marta Garcia-Ramírez
Journal:  J Biomed Biotechnol       Date:  2010-02-17

9.  Impaired reduction of nocturnal systolic blood pressure and severity of diabetic retinopathy.

Authors:  João Soares Felício; Juliana Torres Pacheco; Sandra Roberta Ferreira; Frida Plavnik; Valdir Moisés; Oswaldo Kohlmann Junior; Artur Beltrame Ribeiro; Maria Tereza Zanella
Journal:  Exp Clin Cardiol       Date:  2007

10.  COMPARISON OF 3 MM × 3 MM VERSUS 6 MM × 6 MM OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY SCAN SIZES IN THE EVALUATION OF NON-PROLIFERATIVE DIABETIC RETINOPATHY.

Authors:  Joseph Ho; Kunny Dans; Qisheng You; Eric D Nudleman; William R Freeman
Journal:  Retina       Date:  2019-02       Impact factor: 4.256

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.